Advertisement
Screener

Campbell & CO Investment Adviser LLC Historic Quarter Change: Foreign ADRs, Reduced

Campbell & CO Investment Adviser LLC historic quarter change: Foreign ADRs, Reduced

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 23 quarters from 2013-06-30 to 2026-06-30, Campbell & CO Investment Adviser LLC opened 39 positions, added to 16, reduced 12 and sold out of 50.

  • Q4 2025: Stock Ascendis Pharma A/S; Country of operation —; Class ADR; Shares before 12,009.
  • Q4 2025: Stock Criteo SA; Country of operation —; Class ADR; Shares before 29,160.
  • Q2 2025: Stock AstraZeneca PLC; Country of operation —; Class ADR; Shares before 57,767.
  • Q1 2025: Stock TOTALENERGIES SE; Country of operation —; Class ADR; Shares before 120,237.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1353570), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-03); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-12); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-10-28); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-07); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-14); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-10); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-12); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-13); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-03); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-02); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-07); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-13); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-12); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-12); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-05); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-12); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-06); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-06). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2006-03-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2025Ascendis Pharma A/S
CUSIP 04351P101
ADR12,0092,294-9,715$2,387,509$489,173-$1,898,3362026-02-12
Q4 2025Criteo SA
CUSIP 226718104
ADR29,16019,709-9,451$659,016$406,202-$252,8142026-02-12
Q2 2025AstraZeneca PLC
CUSIP 046353108
ADR57,76734,430-23,337$4,245,875$2,405,968-$1,839,9072025-08-07
Q1 2025TOTALENERGIES SE
CUSIP 89151E109
ADR120,2374,377-115,860$6,552,917$283,148-$6,269,7692025-05-14
Q4 2024ASTRAZENECA PLC
CUSIP 046353108
ADR69,59016,256-53,334$5,421,757$1,065,093-$4,356,6642025-02-10
Q4 2024CRITEO S A
CUSIP 226718104
ADR37,6638,840-28,823$1,515,559$349,710-$1,165,8492025-02-10
Q4 2024BANCOLOMBIA S A
CUSIP 05968L102
ADR17,64611,741-5,905$553,731$369,959-$183,7722025-02-10
Q4 2024ASCENDIS PHARMA A/S
CUSIP 04351P101
ADR6,4766,035-441$966,932$830,838-$136,0942025-02-10
Q3 2024Ascendis Pharma A/S
CUSIP 04351P101
ADR17,2606,476-10,784$2,353,919$966,932-$1,386,9872024-11-12
Q3 2024Criteo SA
CUSIP 226718104
ADR39,28837,663-1,625$1,481,943$1,515,559+$33,6162024-11-12
Q4 2014WUXI PHARMATECH CAYMAN INC
CUSIP 929352102
SPONS ADR SHS24,72511,692-13,033$866,000$394,000-$472,0002015-02-12
Q3 2013ARM HLDGS PLC
CUSIP 042068106
SPONSORED ADR30,23410,386-19,848$1,095,000$500,000-$595,0002013-11-06

Similar Firms

Firm NameCountry13F ValueHoldings
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital AdvisorsUnited States$1.756B403
NEA Management Company, LLCUnited States$1.759B26
Aaron Wealth Advisors LLCUnited States$1.761B691
Symmetry Partners, LLCUnited States$1.750B282
Saratoga Research & Investment ManagementUnited States$1.762B46
Principle Wealth Partners LLCUnited States$1.750B380
Foster Victor Wealth Advisors, LLCUnited States$1.750B243
CAS Investment Partners, LLCUnited States$1.748B5
Simplicity Wealth,LLCUnited States$1.765B748
DNCA FINANCEFrance$1.747B108